Chad Hamilton to Biomarkers, Tumor
This is a "connection" page, showing publications Chad Hamilton has written about Biomarkers, Tumor.
Connection Strength
0.827
-
Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients. Sci Rep. 2021 04 30; 11(1):9371.
Score: 0.149
-
Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. Cancer Med. 2020 02; 9(3):1092-1103.
Score: 0.135
-
Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial. Am J Obstet Gynecol. 2019 11; 221(5):472.e1-472.e10.
Score: 0.131
-
Nestin: A biomarker of aggressive uterine cancers. Gynecol Oncol. 2016 Mar; 140(3):503-11.
Score: 0.103
-
Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells. Gynecol Oncol. 2015 Mar; 136(3):554-61.
Score: 0.096
-
Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. Br J Cancer. 2014 Jan 07; 110(1):123-32.
Score: 0.089
-
Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells. Cancer Prev Res (Phila). 2013 Jul; 6(7):731-43.
Score: 0.086
-
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. J Clin Oncol. 2014 Oct 10; 32(29):3275-83.
Score: 0.024
-
A novel technique for the enrichment of primary ovarian cancer cells. Am J Obstet Gynecol. 2007 Nov; 197(5):507.e1-5.
Score: 0.015